Vodič za dijagnostikovanje i lečenje raka grlića materice - Institut za ...

14. Literatura
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.GLOBOCAN 2008,
Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].Lyon,
France: International Agency for Research on Cancer; 2010. Available from:
http://globocan.iarc.fr
2. World Health Organization, Department of Reproductive Health and Research and
Department of Chronic Diseases and Health Promotion. Comprehensive cervical
cancer control: A guide to essential practice, WHO publications, 2006
3. Ferlay J, Bray F, Pisani P, Parkin DM, eds. Globocan 2002. Cancer Incidence,
Mortality and Prevalence Worldwide (IARC Cancer Bases No. 5. version 2.0), Lyon,
IARCPress, 2004).
4. M. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J.
Worldwide burden of cervical cancer in 2008. Annals of Oncology 2011; 22: 2675–
2686
5. Registar za maligne neoplazme Vojvodine. Sremska Kamenica: Zavod za
epidemiologiju. Institut za onkologiju Vojvodine (nepublikovani podaci), 2012.
6. Incidencija i mortalitet u centralnoj Srbiji, 2009. Registar za rak Srbije, Institut za
zaštitu zdravlja Srbije dr Milan Jovanović- Batut, Centar za kontrolu i prevenciju
nezaraznih oboljenja, Beograd, 2011
7. Solomon D, Davey D, Kurman R, et al.."The 2001 Bethesda System: terminology for
reporting results of cervical cytology". JAMA 2002, 287 (16): 2114–9.
8. Manos MM, Kinney WK, Hurley LB i sar: Identifying women with cervical neoplasia
using human papilloma virus DNA testing for equivocal Papanicolau results. JAMA,
1999; 281: 1605-1610
9. Wright TC, Kurman RJ, Ferenczy A: Precancerous Lesions of the Cervix.
In:Blaustein’s Pathology of the female Genital Tract, 4 th edition, Kurman RJ (ed),
Springer-Verlag, 1995.
10. Friedell GH, Tucker TC, McManmon E i sar: Incidence of dysplasia and carcinoma of
the uterine cervix in an Appalachian population. J Natl Cancer Inst, 1992: 84: 1030-
1032
11. Bosch XF, Manos MM, Munoz N i sar: Prevalence of Human Papillomavirus in
Cervical Cancer: a Worldwide Perspective. J Natl Cancer Inst, 1995; 87: 796-802
12. Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical
management of Human Papillomavirus (HPV) Disease: a critical and systematic
review of the literature in the development of an HPV dynamic transmission model
BMC Infectious Diseases 2009, 9:119 doi:10.1186/1471-2334-9-119
13. Clifford GM, Gallus S, Herrero R, Muńoz N, Snijders PJF et al. Worldwide distribution
of human papillomavirus types in cytologically normal women in the International
Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet
2005; 366: 991–98
14. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch XF de Sanjose S. Cervical Human
Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with
Normal Cytological Findings. The Journal of Infectious Diseases, 2010;202:1789–
1799
15. De Vuyst H, Clifford G, Li N, Franceschi S. HPV infection in Europe. Eur J Cancer,
2009;45: 2632-2639
16. Melkert PWJ, Hopman E, Van Den Brule AJC i sar: Prevalence of HPV in
cytomorphologically normal cervical smears as determined by polimerase chain
reaction, is age-dependent. Int J Cancer, 1993; 53: 919-923
17. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V.
Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. Human papillomavirus is a
necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999; 189:12-9
68